Similar to NK cells, there was a marked interindividual variability in the proliferation of CD4 T cells; and a significant correlation between the percentage of CD4 T cells of CLL patients after lenalidomide treatment and the proliferation of NK cells was observed (r = 0.49, P = 0.04). Here, CD4 is linked to B-cell chronic lymphocytic leukemia.